Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
botulinum toxin type a rho-related gtp-binding protein rhob biotech NA drugbank Neurogenic Thoracic Outlet Syndrome[MeSHID:D013901]
Strabismus[MeSHID:D013285]
Skin Wrinkling[MeSHID:D015595]
Urinary Bladder[MeSHID:D001743]
Trigeminal Neuralgia[MeSHID:D014277]
Pain[MeSHID:D010146]
Facial Nerve Diseases[MeSHID:D005155]
Overactive Bladder[MeSHID:D053201]
Temporomandibular Joint Disorders[MeSHID:D013705]
Hyperhidrosis disorder[MeSHID:D006945]
Disease[MeSHID:D004194]
Spasm[MeSHID:D013035]
Postherpetic neuralgia[MeSHID:D051474]
Neurogenesis[MeSHID:D055495]
Neuralgia[MeSHID:D009437]
Cervical Dystonia[MeSHID:D014103]
Cerebrovascular accident[MeSHID:D020521]
Diabetic Neuropathies[MeSHID:D003929]
Spinal Cord Injuries[MeSHID:D013119]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Blepharospasm[MeSHID:D001764]		 NA approved,investigational inhibitor
botulinum toxin type a synaptosomal-associated protein 25 biotech Successful target TTD , drugbank , DGIDB Neurogenic Thoracic Outlet Syndrome[MeSHID:D013901]
Strabismus[MeSHID:D013285]
Skin Wrinkling[MeSHID:D015595]
Urinary Bladder[MeSHID:D001743]
Trigeminal Neuralgia[MeSHID:D014277]
Pain[MeSHID:D010146]
Facial Nerve Diseases[MeSHID:D005155]
Overactive Bladder[MeSHID:D053201]
Temporomandibular Joint Disorders[MeSHID:D013705]
Hyperhidrosis disorder[MeSHID:D006945]
Disease[MeSHID:D004194]
Spasm[MeSHID:D013035]
Postherpetic neuralgia[MeSHID:D051474]
Neurogenesis[MeSHID:D055495]
Neuralgia[MeSHID:D009437]
Cervical Dystonia[MeSHID:D014103]
Cerebrovascular accident[MeSHID:D020521]
Diabetic Neuropathies[MeSHID:D003929]
Spinal Cord Injuries[MeSHID:D013119]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Blepharospasm[MeSHID:D001764]		 NA approved,investigational inhibitor
click here to return to the previous page